Pregnant women's choices for preventing respiratory syncytial virus (RSV)

被引:0
|
作者
Wang, Bing [1 ,2 ,3 ]
Lassi, Zohra [4 ,5 ]
Andraweera, Prabha [1 ,2 ,3 ]
Chen, Gang [6 ]
Ong, Jason J. [7 ,8 ]
Mcmillian, Mark [1 ,2 ,3 ]
Marshall, Helen [1 ,2 ,3 ]
机构
[1] Womens & Childrens Hlth Network, Vaccinol & Immunol Res Trials Unit, 72 King William Rd, Adelaide, SA 5006, Australia
[2] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia
[3] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia
[4] Univ Adelaide, Robinson Res Inst, Adelaide, Australia
[5] Univ Adelaide, Fac Hlth & Med Sci, Sch Publ Hlth, Adelaide, Australia
[6] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia
[7] Monash Univ, Sch Translat Med, Melbourne, Vic, Australia
[8] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England
关键词
RSV; Maternal vaccine; Vaccine attitudes; Qualitative; Vaccine promotion; VACCINATION; CHALLENGES; CHILDREN;
D O I
10.1016/j.vaccine.2025.126790
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and pneumonia in infants and can lead to severe respiratory distress, especially in very young infants. No specific treatments exist for RSV. However, new preventative strategies have become available including RSV vaccine for pregnant women and monoclonal antibody for infants. This study aimed to identify and understand barriers and facilitators to the uptake of a new RSV vaccine in pregnant women and determine their underlying choices for a maternal RSV immunisation program. Additionally, the study investigated choice for maternal vaccination or administration of a long-lasting monoclonal antibody to infants. Methods: Eligible participants were pregnant women residing in Australia and aged 18 years or older. Focus group discussions and individual online interviews were conducted and data were analysed using a thematic analysis approach. Results: A total of 34 pregnant women participated in online focus group discussions or interviews, with an average age of 34 years. The identified themes were categorised into four overarching domains: 1) motivators for vaccinating during pregnancy to safeguard their babies and prevent severe diseases, 2) barriers to vaccination including vaccine safety concerns, uncertainties regarding vaccine effectiveness, and vaccine hesitancy arising from COVID-19 vaccination experiences, 3) preferred vaccination promotion strategies, including constant reminders/prompts, personalised messages, campaign focusing on serious outcomes and using diverse/lay languages, recommendations from local obstetricians and health authorities, 4) clear vaccine recommendation policies and a preference for maternal immunisation over infant immunisation. Conclusions: The maternal RSV vaccination was generally welcomed and preferred by pregnant women in our study comparing to other strategies. Preferences for RSV program promotion included diversity in languages, "nudge" reminders, and recommendations from healthcare providers.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Respiratory Syncytial Virus (RSV)-Specific Antibodies in Pregnant Women and Subsequent Risk of RSV Hospitalization in Young Infants
    Koivisto, Karoliina
    Nieminen, Tea
    Mejias, Asuncion
    Capella Gonzalez, Cristina
    Ye, Fang
    Mertz, Sara
    Peeples, Mark
    Ramilo, Octavio
    Saxen, Harri
    JOURNAL OF INFECTIOUS DISEASES, 2022, 225 (07): : 1189 - 1196
  • [2] Clinical characteristics and outcomes of respiratory syncytial virus infection in pregnant women
    Hause, Anne M.
    Avadhanula, Vasanthi
    Maccato, Maurizio L.
    Pinell, Phillip M.
    Bond, Nanette
    Santarcangelo, Patricia
    Ferlic-Stark, Laura
    Ye, Xunyan
    Iwuchukwu, Obinna
    Maurer, Lauren
    Aideyan, Letisha
    Dao, Kelly
    McBride, Trevor
    Piedra, Pedro A.
    Munoz, Flor M.
    VACCINE, 2019, 37 (26) : 3464 - 3471
  • [3] The dawn of preventing respiratory syncytial virus lower respiratory tract infections in children
    Dangor, Z.
    Madhi, S. A.
    Zar, H. J.
    Demopoulos, D.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2024, 114 (12): : 14 - 17
  • [4] Preventing respiratory syncytial virus in infants
    Moe, Samantha S.
    Wong, Sam
    Kolber, Michael R.
    CANADIAN FAMILY PHYSICIAN, 2024, 70 (10)
  • [5] Preventing respiratory syncytial virus infections
    Robinson, J. L.
    PAEDIATRICS & CHILD HEALTH, 2011, 16 (08) : 487 - 488
  • [6] Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
    Gatt, Dvir
    Martin, Isaac
    AlFouzan, Rawan
    Moraes, Theo J. J.
    PATHOGENS, 2023, 12 (02):
  • [7] Development of respiratory syncytial virus (RSV) vaccines for infants
    Gerretsen, Hannah E.
    Sande, Charles J.
    JOURNAL OF INFECTION, 2017, 74 : S143 - S146
  • [8] New strategies for the prevention of respiratory syncytial virus (RSV)
    Messina, Alessandro
    Germano, Chiara
    Avellis, Vincenzo
    Tavella, Elena
    Dodaro, Valentina
    Massaro, Alessandro
    Vitale, Raffaele
    Masturzo, Bianca
    Manzoni, Paolo
    EARLY HUMAN DEVELOPMENT, 2022, 174
  • [9] Preventing Pediatric Respiratory Syncytial Virus Infection
    Domachowske, Joseph
    Halczyn, Jodi
    Bonville, Cynthia A.
    PEDIATRIC ANNALS, 2018, 47 (09): : E371 - E376
  • [10] Preventing hospitalizations for respiratory syncytial virus infection
    Robinson, Joan L.
    Le Saux, Nicole
    PAEDIATRICS & CHILD HEALTH, 2015, 20 (06) : 322 - 327